Report

Ubistatins Inhibit Proteasome-Dependent Degradation by Binding the Ubiquitin Chain

See allHide authors and affiliations

Science  01 Oct 2004:
Vol. 306, Issue 5693, pp. 117-120
DOI: 10.1126/science.1100946

You are currently viewing the abstract.

View Full Text

This article has a correction. Please see:

Abstract

To identify previously unknown small molecules that inhibit cell cycle machinery, we performed a chemical genetic screen in Xenopus extracts. One class of inhibitors, termed ubistatins, blocked cell cycle progression by inhibiting cyclin B proteolysis and inhibited degradation of ubiquitinated Sic1 by purified proteasomes. Ubistatins blocked the binding of ubiquitinated substrates to the proteasome by targeting the ubiquitin-ubiquitin interface of Lys48-linked chains. The same interface is recognized by ubiquitin-chain receptors of the proteasome, indicating that ubistatins act by disrupting a critical protein-protein interaction in the ubiquitin-proteasome system.

View Full Text